Now showing items 1-2 of 2

    • Immunogenicity of Fractional Doses of Tetravalent A/C/Y/W135 Meningococcal Polysaccharide Vaccine: Results from a Randomized Non-Inferiority Controlled Trial in Uganda 

      Guerin, Philippe J.; Næss, Lisbeth M.; Fogg, Carole; Rosenqvist, Einar; Pinoges, Loretxu; Bajunirwe, Francis; Nabasumba, Carolyn; Borrow, Ray; Frøholm, Leif O.; Ghabri, Salah; Batwala, Vincent; Twesigye, Rogers; Aaberge, Ingeborg S.; Røttingen, John-Arne; Piola, Patrice; Caugant, Dominique A. (PLoS Negl Trop Dis, 2008)
      Background: Neisseria meningitidis serogroup A is the main causative pathogen of meningitis epidemics in sub-Saharan Africa. In recent years, serogroup W135 has also been the cause of epidemics. Mass vaccination campaigns ...
    • Pharyngeal carriage of Neisseria meningitidis in 2—19-year-old individuals in Uganda 

      Cauganta, Dominique A.; Foggd, Carole; Bajunirwe, Francis; Piola, Patrice; Twesigye, Rogers; Mutebi, Fred; Frøholma, L. Oddvar; Rosenqvist, Einar; Batwala, Vincent; Aaberge, Ingeborg S.; Rottingen, John-Arne; Guerin, Philippe J. (Transactions of the Royal Society of Tropical Medicine and Hygiene, 2006)
      In southern Uganda, only sporadic cases of serogroup A meningococcal disease have been reported since 2000. As part of an immunogenicity study of the tetravalent meningococcal polysaccharide vaccine, nasopharyngeal swab ...